Life WhispererLife WhispererLife WhispererLife Whisperer
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Embryo Quality
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial

Life Whisperer Genetics AI shows robust performance at varying times and stages of embryo development

AI Healthcare company Presagen, in collaboration with Ovation Fertility (USA), Alpha Fertility (Malaysia), Wings Fertility (India) and IVF-Life (Europe), presented an international study on Life Whisperer at the European Society of Human Reproduction and Embryology (ESHRE) 2023 Annual Meeting, June 2023 in Copenhagen.

Life Whisperer uses Artificial Intelligence to assess images of IVF patients’ embryos to evaluate their quality, in order to improve IVF outcomes. Life Whisperer uses two AI algorithms. Life Whisperer Viability AI assesses embryo images to evaluate how likely they are to lead to a pregnancy, and Life Whisperer Genetics AI non-invasively assesses embryo genetic integrity (euploidy) from morphology.

The study showed that Life Whisperer Genetics AI’s predictive ability for identifying euploidy was robust to varying stages of embryo development (blastocyst expansion grade) and time-points on day 5 of in vitro culture. It was also discovered that the time point that achieved greatest predictive ability was 120 hours post-fertilization.

These recent findings suggest that the AI is providing additional information regarding embryo genetic status over and above that provided by known morphological parameters. They also show that regardless of expansion grade, predictivity is optimized when embryos are assessed at the same time-point on day 5, preferably closer to the 120 hour time-point.

This study is important for the IVF and AI industries because it further validates the potential for AI imaging to provide a non-invasive, low cost, and instant assessment of embryo genetic integrity to support IVF treatment.

Download the poster here.

Life Whisperer

Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.

Presagen

Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.

Connect with us
Share
0

Related posts

September 4, 2023

Life Whisperer AI featured in three oral presentations at the Asia Pacific fertility conference, ASPIRE 2023


Read more
August 22, 2023

Presagen sponsors Women’s Health Innovation Summit (WHIS) USA to support the future health of woman-kind


Read more
August 16, 2023

Can analysis of embryo appearance using artificial intelligence provide insight into the sex of your baby, and help prevent male bias in IVF?


Read more
August 8, 2023

Independent study shows Life Whisperer’s AI can predict the viability of embryos that have previously been frozen


Read more

Comments are closed.

HIPAA and GDPR compliant and ISO 13485 certified.

CE Logo

Life Whisperer Viability and Genetics are commercially available in Australia, Canada, Europe (EEA), UK, Japan, India, UAE, Hong Kong, Israel, Malaysia, Thailand, Vietnam, Singapore, New Zealand, Turkey, Trinidad & Tobago, and Guyana (not available in the USA).

Life Whisperer Genetics is commercially available in the USA.

For sale to healthcare professionals only.

© Life Whisperer Diagnostics Pty Ltd     Terms and conditions   |   Privacy Policy   |   Fair Use Policy
  • Home
  • Products
  • Distribution
  • News & Science
  • About
  • Request a Trial